The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Trabectedin and indole-3-carbinol combination in heavily pretreated metastatic breast cancer: Results of a pilot clinical study.
Alberto Zambelli
No relevant relationships to disclose
Richard Tancredi
No relevant relationships to disclose
Sara Negri
No relevant relationships to disclose
Carlo Cattrini
No relevant relationships to disclose
Luisa Ponchio
No relevant relationships to disclose
Mara Frascaroli
No relevant relationships to disclose
Gian Antonio Da Prada
No relevant relationships to disclose
Vittorio Fregoni
No relevant relationships to disclose
Lorenzo Pavesi
No relevant relationships to disclose
Alberto Riccardi
No relevant relationships to disclose
Massimo Zucchetti
No relevant relationships to disclose
Ilaria Fuso Nerini
No relevant relationships to disclose
Maurizio D'Incalci
Consultant or Advisory Role - PharmaMar
Honoraria - PharmaMar
Research Funding - PharmaMar